Drugs / MPC-SHRC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03129295 | Apr → Sep 2017 | urinary tract infection | Mission Pharmacal | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MPC-SHRC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03129295 ↗ |
| Route | Oral | “Oral tablet four times a day for 3 days” NCT03129295 ↗ |